Global Dry Eye Syndrome Market Report 2021: Market Reached a Value of $3.9 Billion in 2020 - Industry Trends, Share, Size, Growth, Opportunity and Forecast to 2026 - ResearchAndMarkets.com

·4 min read

The "Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global dry eye syndrome market reached a value of US$ 3.9 Billion in 2020. Looking forward, the global dry eye syndrome market to exhibit moderate growth during the next five years.

Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc.

Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes.

It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population.

With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.

Key Questions Answered in This Report:

1. What was the global dry eye syndrome market size in 2020?

2. What will be the global dry eye syndrome market outlook during the forecast period (2021-2026)?

3. What are the global dry eye syndrome market drivers?

4. What are the major trends in the global dry eye syndrome market?

5. What is the impact of COVID-19 on the global dry eye syndrome market?

6. What is the global dry eye syndrome market breakup by disease type?

7. What is the global dry eye syndrome market breakup by drug type?

8. What is the global dry eye syndrome market breakup by product?

9. What is the global dry eye syndrome market breakup by distribution channel?

10. What are the major regions in the global dry eye syndrome market?

Breakup by Disease Type:

  • Evaporative

  • Aqueous

Based on the disease type, evaporative dry eye syndrome currently accounts for the highest market share.

Breakup by Drug Type:

  • Anti-inflammatory Drugs

  • Lubricant Eye Drops

  • Autologous Serum Eye Drops

Based on the drug type, anti-inflammatory drugs currently account for the highest market share.

Breakup by Product:

  • Liquid Drops

  • Gel

  • Liquid Wipes

  • Eye Ointment

  • Others

Based on the product type, liquid eye drops currently account for the highest market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Based on the distribution type, hospital pharmacies currently account for the highest market share.

Breakup by Region:

  • North America

  • Europe

  • Asia Pacific

  • Middle East and Africa

  • Latin America

On the geographical front, North America currently represents the biggest market for dry eye syndrome.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being, Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/esax1z.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210419005701/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900